ADPT
Adaptive Biotechnologies Corp
28.60$
+0.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 56.6% | 54.3% | 67.2% | 65.1% | 43.6% | 65.6% | 62.0% | 52.6% | 58.5% | |
| 23.5% | 16.5% | 10.6% | 11.1% | 15.1% | 10.5% | 9.8% | 8.9% | 13.7% | |
| 53.0% | 49.6% | 63.2% | 61.6% | 38.2% | 58.2% | 52.4% | 41.2% | 44.3% | |
| 1.5% | 1.4% | 1.4% | 0.9% | 1.9% | 4.7% | 5.7% | 7.7% | 9.8% | |
| 1.3% | 2.4% | 1.0% | 1.3% | 2.1% | 1.7% | 2.2% | 1.6% | 1.9% | |
| 3.8% | 5.7% | 2.6% | 3.6% | 9.2% | 9.7% | – | – | – | |
| 32.8% | 35.8% | 13.0% | 10.7% | 12.9% | 13.9% | 18.0% | 22.1% | 23.2% | |
| 4.2% | 4.1% | 1.3% | 0.9% | 0.9% | 0.8% | 0.8% | 0.6% | 0.3% | |
| 162.0% | 177.6% | 37.4% | 33.4% | 34.6% | 45.8% | 53.4% | 62.5% | 56.1% | |
| 5.8% | 6.9% | 8.6% | 9.4% | 12.3% | 12.8% | 13.3% | 18.2% | 17.5% | |
| 0.0% | 0.0% | – | 0.3% | 0.5% | 1.1% | 1.4% | 1.9% | 2.6% | |
| 0.5% | 0.5% | 0.5% | 0.3% | 0.4% | 0.9% | 1.2% | 1.3% | 1.3% | |
| 0.1% | 0.1% | – | – | – | – | – | – | – | |
| -62.0% | -77.6% | 62.6% | 66.6% | 65.4% | 54.2% | 46.6% | 37.6% | 42.7% | |
| -68.8% | -88.9% | -40.1% | -45.8% | -77.9% | -107.3% | -173.1% | -241.7% | -265.9% | |
| 29.1% | 31.7% | 13.6% | 11.8% | 15.2% | 16.6% | 21.8% | 27.3% | 29.6% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.